🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety and efficacy of intramuscular injection o...
Status
Unknown
Location
ILD Research Center
Start Date
2020-01-30
Trial ID
NCT04267640
The purpose of the study is to confirm the feasibility of study procedures ...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2013-11
Trial ID
NCT02016755
Treatments Being Tested
A double-blind, randomized, placebo-controlled, single-center, 12-month pha...
Status
Withdrawn
Location
Translational Pain Research, Brigham and Women's Hospital
Start Date
2019-11
Trial ID
NCT04087941
Treatments Being Tested
The purpose of this study is to evaluate the safety and clinical efficacy o...
Status
Withdrawn
Location
GangNeung Asan Hospital
Start Date
2018-01-25
Trial ID
NCT03404024
The purpose of this study is to evaluate whether intramuscular injections o...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2019-08-28
Trial ID
NCT04274049
Treatments Being Tested
The purpose of this study is to evaluate whether PET/CT-RGD or MIBI can be ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2022-07-29
Trial ID
NCT05968118
The purpose of this study is to evaluate whether intramuscular injections o...
Status
Completed
Location
Cardiology PC
Start Date
2010-07-09
Trial ID
NCT01064440
Treatments Being Tested
The primary purpose of this study was to assess the overall safety of diffe...
Status
Completed
Location
Cardiology, P.C.
Start Date
2003-04
Trial ID
NCT00060892
Treatments Being Tested
The purpose of this study is to evaluate whether intramuscular injections o...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2012-03
Trial ID
NCT01548378
Treatments Being Tested
To evaluate the safety and efficacy of recombinant human hepatocyte growth ...
Status
Completed
Location
Beijing Hospitai
Start Date
2019-08-02
Trial ID
NCT04275323
Treatments Being Tested